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Objective: Use of vaginal meshes for treatment of pelvic organ prolapse (POP) remains controversial. A
trend toward abdominal approaches and the development of new meshes has been noted. We compared
the 1-year results of two different approaches using new lightweight meshes.
Materials and methods: Sixty-nine (95.8%) of 72 women with POP Stage  2, who underwent laparo-
scopic sacrocolpopexy (LSC) (n ¼ 39) or a total vaginal mesh (TVM) procedure (n ¼ 30) using lightweight
polypropylene meshes, were studied. Baseline and follow-up assessments included a pelvic examination
and a composite condition-speciﬁc questionnaire. A detailed comparison of 1-year outcomes was made.
Data were analyzed using appropriate statistical methods.
Results: Compared to the TVM group, the LSC group was characterized by a younger age (53.7 years vs.
64.1 years, p < 0.001) and a longer operating time (264 minutes vs. 177.6 minutes, p < 0.001). Objective
anatomic success (POP Stage  1) rates were similar between groups after statistical adjustment, i.e.,
84.6% (33/39) and 86.7% (26/30) after LSC and TVM (p ¼ 0.94), respectively. However, the dominant
recurrence sites were different with anterior (n ¼ 6) most frequent after LSC and apical (n ¼ 4) most
frequent after TVM. Reoperations were needed for the four (13.3%) apical recurrences in the TVM group.
No serious complications were noted. We found “cystocele as the dominant prolapse” (p ¼ 0.016; odds
ratio ¼ 6.94) and “suspension of prolapsed (POP Stage  2) uterus” (p ¼ 0.025; odds ratio ¼ 7.00)
signiﬁcantly affected recurrence after LSC and TVM, respectively.
Conclusion: POP repair by LSC or TVM using the new lightweight polypropylene meshes seems to be safe
and has comparable outcomes, but limitations may vary.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Use of vaginal meshes for treatment of pelvic organ prolapse
(POP) has resulted in high success rates in anatomic reconstruction
[1,2]. However, widespread use of vaginal meshes remains
controversial due to potential serious complications [1e3].
Following the withdrawal of some commercial kits from thes and Gynecology, Taichung
Section 4, Taichung, 40705,
).
bstetrics & Gynecology. Publishedmarket, there has been a shift to abdominal approaches [4e8] and
the development of new surgical meshes [7e12].
Abdominal sacrocolpopexy has become the gold standard for
POP [13]. An updated Cochrane review showed the procedure has
better outcomes than a variety of vaginal procedures, including
vaginal meshes, in terms of a higher objective success rate, a lower
reoperation rate, and dyspareunia. However, it is also associated
with a longer operating time, longer time to return to daily activ-
ities, and increased cost [2]. Nevertheless, these disadvantages
need to be balanced against the recently introduced less-invasive
methods such as laparoscopy or robot-assisted laparoscopy
[6,14e16].by Elsevier Taiwan LLC. All rights reserved.
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development of new surgical meshes in an attempt to minimize
mesh-related complications [17]. Two such kinds of meshes are
available for clinical use at present, i.e., lightweight and partially
absorbable polypropylene meshes [7e12]. Favorable results have
been reported in both safety and efﬁcacy proﬁles after sacro-
colpopexy procedures using the new lightweight Y-shaped mesh
[7,8]. In addition, the use of the lightweight or partially absorbable
meshes in vaginal POP repair seems to contribute to a lower rate of
vaginal mesh extrusion compared to the original meshes, which
may or may not have a higher recurrence rate [9e12].
Maher et al [14] conducted a randomized controlled trial (RCT)
to compare laparoscopic sacrocolpopexy (LSC) with a total vaginal
mesh (TVM) procedure using original standard-weight poly-
propylene meshes for prolapse repair. A higher success rate and
lower reoperation rate were noted after LSC when compared to
TVM [14]. We hypothesized that the two procedures may have
comparable surgical outcomes using the new lightweight meshes.
The objective of this study was to compare 1-year results of the two
procedures.
Materials and methods
Study protocol
This was a non-randomized controlled study conducted at a
tertiary referralmedical center in Taiwan. Between January 2012 and
December 2012, women who were referred for mesh-augmented
POP repair were enrolled consecutively. The inclusion and exclu-
sion criteria were described in our previous study [18]. In brief, pa-
tients who presented with a symptomatic POP Stage 2 and did not
have a previous prolapse mesh repair, hysterectomy within 6
months of the index surgeries, diseases known to affect bladder or
bowel function, and were able to complete the study, were enrolled.
Patients were either counseled to undergo an LSC using a light-
weight Y-shaped polypropylene mesh (Alyte; C.R. Bard, Covington,
GA, USA) or a TVM procedure using a partially absorbable poly-
propylene mesh (Prolift þ M; Ethicon, Somerville, NJ, USA). All pa-
tients gave informed consent after they received a full explanation of
the procedure. The primary outcome measures were objective
anatomic success rates and functional results. The secondary
outcome measures were surgical complications and reoperations.
Baseline assessment
Prior to the operation, all patients were interviewed and were
required to complete a composite condition-speciﬁc questionnaire
containing the short-form Pelvic Floor Distress Inventory (PFDI-20),
Pelvic Floor Impact Questionnaire (PFIQ-7) [19], and the short-form
Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire
(PISQ-12) [20]. All patients also underwent a pelvic examination
and a multichannel urodynamic study. POP was quantiﬁed ac-
cording to the Pelvic Organ Prolapse Quantiﬁcation (POPQ) system
[21]. The urodynamic study was performed according to the
methods, deﬁnitions, and units which conform to the standards
proposed by the International Urogynecological Association and
the International Continence Society [22].
Surgical intervention
Operations were performed according to the surgical technique
that was described by Maher et al [14] with some modiﬁcations to
LSC for uterine preservation similar to the methods described by
Lee et al [23]. The lightweight Y-shaped mesh (Alyte; C.R. Bard)
used in LSC has a density of <20 g/m2 in contrast to the originalheavy (95 g/m2) mesh (Marlex; C.R. Bard) [8]. The mesh was fash-
ioned to suit the individual with the anterior leaf 5 cm and the
posterior leaf 7 cm in length, respectively. The partially absorbable
polypropylene mesh (Prolift þ M; Ethicon, Somerville, NJ, USA)
used in TVM was reported to have a density of 57 g/m2 and, after a
full absorption following implantation, has a ﬁnal density of 31 g/
m2 as opposed to the 45 g/m2 of the original mesh [10]. The surgical
team (M.-J.H. and C.-P.T.) was skilled in laparoscopic and vaginal
reconstructive surgeries with or without meshes. Concomitant
surgeries were performed as indicated, including a hysterectomy
(total or subtotal), a mid-urethral sling (TVT-O; Ethicon) and a
perineorrhaphy. Hysterectomy was performed only if uterine or
cervical pathology was found at baseline assessment or on patient
request. Postoperatively, all patients underwent transurethral
bladder drainage. A voiding trial began on postoperative Day 3. A
patient's catheter was removed once the patient could void freely
and the post-void residual was <25% of the total bladder volume
and <100 mL on two occasions.
Follow-up investigation
Follow-up examinations were performed at the postoperative 3-,
6-, and 12-month visits, and then annually. Follow-up assessment
and data collectionwere performed by a clinical research fellow (C.-
K.L.) who was blinded to patient baseline data to eliminate bias. The
surgery was considered successful in patients who were free of
bulge or pressure symptoms and in whom the vaginal support was
POPQ Stage  1. Functional outcome was measured by comparing
the pre- and postoperative scorings on the PFDI-20, PFIQ-7, and
PISQ-12, respectively. Patients were encouraged to engage in sexual
intercourse 3 months after surgery. Dyspareunia was deﬁned as an
answer of2 (“sometimes”) to Question 5 of the 12-month PISQ-12.
During each postoperative pelvic examination, the research fellow
looked for evidence of vaginal mesh extrusion and stress urinary
incontinence by using a cough stress test.
Statistical analysis
Clinical data are presented as mean ± standard deviation, me-
dian (range), or percentage when appropriate. Univariate analysis
was used to compare the demographic and surgical data, POPQ
stages and various parameters, and functional results between
groups. The association between objective anatomic outcome and
important clinical variables was examined by a multivariate logistic
regression analysis. Sixteen variables [i.e., age, body mass index,
parity, diabetes, point B anterior (Ba), cervix or vaginal cuff (C),
point B posterior (Bp), and genital hiatus (GH) values, three indi-
vidual and the total POPQ stages, dominant prolapse sites, previous
prolapse surgery, suspension of prolapsed (Stage 2) uterus, and
concomitant mid-urethral sling] were tested by using forward se-
lection methods. A p value of <0.05 was considered as statistically
signiﬁcant. Statistical analyses were performed using SAS 9.2
software (SAS Institute Inc, Cary, North Carolina, USA).
Results
Patient characteristics
Of the 72 patients enrolled, three (1 LSC and 2 TVM) were lost to
follow-up at 1 year. The remaining 69 (95.8%) women, who un-
derwent an LSC (n¼ 39) or a TVMprocedure (n¼ 30), were studied.
Demographic data are shown in Table 1. Compared to the TVM
group, the LSC group was characterized by a signiﬁcantly younger
age at operation, lower parity, lower body mass index, and a lower
percentage of menopause. The majority of patients enrolled did not
Table 1
Preoperative characteristics of patients who underwent laparoscopic sacrocolpopexy (LSC) or a total vaginal mesh (TVM) procedure using lightweight polypropylene meshes.
Patient characteristics LSC (n ¼ 39) TVM (n ¼ 30) p
Value Range Value Range
General data
Mean age (y) 53.7 ± 6.6 (33e65) 64.1 ± 7.7 (45e78) <0.001a
Median parity 2 (0e4) 3 (0e7) <0.001a
Mean body mass
index (kg/m2)
24.0 ± 2.9 (17.4e29.9) 25.8 ± 3.2 (18.9e32.9) 0.018a
Menopause 60.0 (23/39) 93.3 (28/30) 0.009b
Sexual activity 35.9 (14/39) 10.0 (3/30) 0.067b
Previous hysterectomy 10.3 (4/39) 10.0 (3/30) >0.99b
Previous prolapse repair 7.7 (3/39) 6.7 (2/30) >0.99b
Diabetes mellitus 12.8 (5/39) 26.7 (8/30) 0.366b
Urodynamic diagnoses
Bladder hypersensitivity 41 (16/39) 43.3 (13/30) >0.99b
Detrusor overactivity 10.3 (4/39) 3.3 (1/30) 0.375b
Urodynamic stress
incontinence
35.9 (14/39) 33.3 (10/30) 0.619b
Bladder outlet obstruction 33.3 (13/39) 23.3 (7/30) 0.422b
Detrusor underactivity 12.8 (5/39) 16.7 (5/30) 0.738b
Data are presented as % or mean ± SD, unless otherwise indicated.
a Mann-Whitney test.
b Fisher's exact test.
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groups included mainly primary POP cases. Preoperative urody-
namic diagnoses were also not signiﬁcantly different between the
two groups.
Surgical results
Surgical data are summarized in Table 2. Perioperative outcomes
included a signiﬁcantly shorter hospital stay, shorter catheteriza-
tion time, and less estimated blood loss, but a longer operating time
in the LSC group compared to the TVM group. The percentages of
patients undergoing various concomitant surgeries were also
comparable between groups. Postoperatively, there was no signif-
icant difference between groups regarding the surgical effective-
ness for POP and stress urinary incontinence. The rates of variousTable 2
Surgical results of patients who underwent laparoscopic sacrocolpopexy (LSC) or a total
Parameters LSC (n ¼ 39)
Value Range
Perioperative data
Mean hospital stay (d) 4.6 ± 0.7 (3e7)
Mean Foley drainage (d) 3.2 ± 0.8 (3e8)
Mean operating time (min) 264 ± 37.8 (210e3
Mean estimated blood loss (mL) 133.3 ± 95.5 (50e40
Mean pain score (next day) 2.84 ± 0.55 (2e4)
Concomitant surgeries
Hysterectomy (subtotal/total) 25.7 (9/35)
Midurethral sling 35.9 (14/39)
Perineorrhaphy 71.8 (28/39)
Surgical effectiveness
Pelvic organ prolapse (Stage 1) 84.6 (33/39)
Stress urinary incontinence (cure) 100 (14/14)
Surgical complications
Perioperative blood transfusion 0 (0/39)
Pelvic hematoma formation 0 (0/39)
Pelvic inﬂammatory disease 2.6 (1/39)
Delayed free voiding (>7d) 2.6 (1/39)
De novo stress incontinence 11.5 (3/26)
De novo urgency incontinence 5.3 (2/38)
Vaginal mesh extrusion 0% (0/39)
Data are presented as % or mean ± SD, unless otherwise indicated.
a Mann-Whitney test.
b Fisher's exact test.complications were acceptable and not signiﬁcantly different be-
tween groups. De novo stress incontinence had the highest rate of
complications in both groups. Of the seven patients who had this
complication, only one (2.6%) in the LSC group underwent a mid-
urethral sling procedure (TVT; Ethicon); the others considered their
symptoms tolerable and chose to continue expectancy manage-
ment. Only one (3.3%) patient in the TVM group had vaginal mesh
extrusion concomitantly with a Stage 2 recurrent uterine prolapse,
which was managed by a simple mesh excision and a vaginal
trachelectomy.
Anatomic outcomes, assessed by comparing the pre- and post-
operative POPQ stages and various parameters, are shown in
Table 3. There was a statistically signiﬁcant improvement in all
POPQ stages of the three vaginal compartments after both pro-
cedures. However, a signiﬁcant (p¼ 0.01) difference in POPQ stagesvaginal mesh (TVM) procedure using lightweight polypropylene meshes.
TVM (n ¼ 30) p
Value Range
5.7 ± 1.0 (5e8) <0.001a
3.6 ± 1.6 (3e11) 0.031a
60) 177.6 ± 38.6 (120e290) <0.001a
0) 246.6 ± 200.4 (50e1100) 0.001a
3.07 ± 0.91 (2e6) 0.601a
22.2 (6/27) >0.99b
33.3 (10/30) 0.619b
70.0 (21/30) >0.99b
86.7 (26/30) >0.99b
80 (8/10) 0.153b
3.3 (1/30) 0.435b
0 (0/30) >0.99b
0 (0/30) 0.435b
3.3 (1/30) >0.99b
20 (4/20) 0.488b
3.6 (1/28) >0.99b
3.3% (1/30) 0.435b
Table 3
Anatomic outcome assessed at 1-year follow-up by the Pelvic Organ Prolapse Quantiﬁcation (POPQ) system in patients who underwent laparoscopic sacrocolpopexy (LSC) or a
total vaginal mesh (TVM) procedure using lightweight polypropylene meshes.
LSC (n ¼ 39) TVM (n ¼ 30) pb postoperative groups
Preoperative Postoperative pa Preoperative Postoperative pa
POPQ Stages
Anterior site <0.001 <0.001 0.120
Stage 0eI 8 (20.5) 33 (84.6) 0 (0) 28 (93.3)
Stage II 13 (33.3) 6 (15.4) 7 (23.3) 2 (6.6)
Stage III 17 (43.6) 0 (0) 18 (60) 0 (0.0)
Stage IV 1 (2.6) 0 (0) 5 (16.7) 0 (0)
Apical site <0.001 <0.001 0.012
Stage 0eI 2 (5.1) 39 (100) 7 (23.3) 26 (86.7)
Stage II 14 (35.9) 0 (0) 7 (23.3) 3 (10)
Stage III 12 (30.8) 0 (0) 12 (40) 1 (3.3)
Stage IV 11 (28.2) 0 (0) 4 (13.3) 0 (0)
Posterior site <0.001 <0.001 0.254
Stage 0eI 7 (17.9) 39 (100) 3 (10) 29 (96.7)
Stage II 17 (43.6) 0 (0) 19 (63.4) 1 (3.3)
Stage III 14 (35.9) 0 (0) 4 (13.8) 0 (0)
Stage IV 1 (2.6) 0 (0) 4 (13.8) 0 (0)
POPQ parameters
point A anterior (Aa) 0.23 ± 2.61 2.62 ± 0.81 <0.001 1.05 ± 1.56 2.97 ± 0.18 <0.001 0.032
point B anterior (Ba) 1.76 ± 3.06 2.51 ± 0.99 <0.001 3.35 ± 2.10 2.8 ± 0.66 <0.001 0.108
cervix or vaginal cuff (C) 2.81 ± 3.27 7.25 ± 0.8 <0.001 2.15 ± 3.84 5.83 ± 3.01 <0.001 0.030
point A posterior (Ap) 0.31 ± 2.07 3.00 ± 0 <0.001 0.47 ± 1.76 2.90 ± 0.55 <0.001 0.254
point B posterior (Bp) 0.94 ± 3.03 3.00 ± 0 <0.001 0.83 ± 2.69 2.87 ± 0.73 <0.001 0.254
posterior fornix (if cervix is present) (D) 0.69 ± 3.59 7.97 ± 0.84 <0.001 0.65 ± 3.99 6.43 ± 2.89 <0.001 0.151
genital hiatus (GH) 3.99 ± 0.54 2.68 ± 0.56 <0.001 3.82 ± 0.43 2.67 ± 0.59 <0.001 >0.999
perineal body (PB) 2.00 ± 0.50 3.28 ± 0.54 <0.001 2.15 ± 0.33 3.45 ± 0.53 <0.001 0.132
total vaginal length (TVL) 7.74 ± 0.64 8.83 ± 0.74 <0.001 7.87 ± 0.74 8.02 ± 0.76 0.226 <0.001
Data are presented as n (%) or mean ± SD, unless otherwise indicated.
a Wilcoxon test.
b Mann-Whitney test.
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ment. In contrast to no recurrence (POPQ Stage  2) in the middle
compartment after LSC, there were four (13.3%) apical recurrences
after TVM. POPQ parameters improved signiﬁcantly after both
procedures except for a stable TVL after TVM. In addition, the dif-
ference in various POPQ parameters between postoperative groups
showed a signiﬁcant improvement after LSC at point C and TVL and
after TVM at point Aa. During the 1-year follow-up examination, a
total of 10 patients were found to have anatomic recurrence (POPQ
Stage 2; Table 4). Cystocele (n¼ 6) and apical prolapse (n¼ 4) had
the highest recurrence rates after LSC and TVM, respectively. Only
one (1/6) cystocele after LSC was symptomatic and no further op-
erations were needed. By contrast, all four (4/4) patients with apical
prolapse after TVM were symptomatic and reoperations were
necessary. The subjective anatomic success rates were therefore
97.4% (38/39) and 86.7% (26/30) after LSC and TVM, respectively.Table 4
Characteristics of the 10 patients who had anatomic recurrence (POPQ Stage  2) after
lightweight polypropylene meshes.
Case Age (y) Operation
Procedure Uterine condition
1 49 LSC Conservation
2 55 LSC Conservation
3 63 LSC Suspension
4 56 LSC Hysterectomy
5 55 LSC Suspension
6 68 LSC Vault suspension
7 64 TVM Suspension
8 47 TVM Suspension
9 66 TVM Suspension
10 67 TVM HysterectomyFunctional outcomes, assessed by comparing the pre- and
postoperative scores, are shown in Table 5. A statistically signiﬁcant
improvement was noted in various pelvic symptoms and quality-
of-life indexes except for stable sexual functioning after both pro-
cedures. The rates of sexual activity increased signiﬁcantly after
both procedures and were not signiﬁcantly different between
postoperative groups. The rates of dyspareunia were unchanged
before and after the two procedures and were also not signiﬁcantly
different between postoperative groups.
Outcome analysis
The objective anatomic success (POPQ Stage  1) rates were
similar (p¼ 0.94) between groups after statistical adjustment. After
a multivariate logistic regression analysis, we found “cystocele as
the dominant prolapse” (p ¼ 0.016; odds ratio ¼ 6.94) andlaparoscopic sacrocolpopexy (LSC) or a total vaginal mesh (TVM) procedure using
POPQ parameters
Pre-/Postoperative
Subsequent management
Ba C Bp
0/1 3/6 2/3 Observation
þ3/1 28 3/3 Observation
þ4.5/0 þ4/7 1/3 Observation
þ5/0 þ9/8 þ1/3 Observation
þ4/0 0/6.5 0/3 Observation
þ6/0 þ7/8 þ6/3 Observation
0/1 þ3/0 2/3 Trachelectomy
0/3 þ4/0 1/3 Trachelectomy
þ3/3 0/1 1/þ1 Trachelectomy
þ2/0 þ9/þ4 þ2/3 LSC
Table 5
Functional outcome assessed at 1-year follow-up by comparing the pre- and postoperative symptoms and quality-of-life scores in patients who underwent laparoscopic
sacrocolpopexy (LSC) or a total vaginal mesh (TVM) procedure using lightweight polypropylene meshes.
LSC (n ¼ 39) TVM (n ¼ 30)
Preoperative
values
Postoperative
values
pa Preoperative
values
Postoperative
values
pa pc postoperative
groups
PFDI-20 18.6 ± 12.7 4.0 ± 1.8 <0.001 18.2 ± 12.3 4.2 ± 1.7 <0.001 0.663
POPDI-6 7.9 ± 5.6 1.0 ± 1.8 <0.001 8.9 ± 4.8 0.8 ± 1.3 <0.001 0.735
UDI-6 6.3 ± 4.7 2.8 ± 2.6 <0.001 6.0 ± 4.7 2.5 ± 3.0 <0.001 0.549
CRADI-8 3.7 ± 4.7 0.7 ± 1.3 0.003 3.1 ± 3.3 0.8 ± 1.2 0.004 0.707
POPIQ-7 8.8 ± 6.0 1.9 ± 3.7 <0.001 10.2 ± 7.8 2.2 ± 3.8 <0.001 0.775
PISQ-12 32.7 ± 8.3 35.2 ± 6.8 0.350 28.7 ± 7.1 33.9 ± 4.2 0.180 0.205
Sexual activity 35.9 (14/39) 59.0 (23/39) 0.031b 10.0 (3/30) 56.7 (17/30) <0.001b 0.805d
Dyspareunia 28.6 (4/14) 26.1 (6/23) 0.500b 33.3 (1/3) 29.4 (5/17) >0.999b >0.999d
Data are presented as % (n/N) or mean ± SD, unless otherwise indicated.
a Wilcoxon test.
b McNemar test.
c Mann-Whitney test.
d Fisher's exact test.
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ratio ¼ 7.00) signiﬁcantly affected recurrence after LSC and TVM,
respectively. The objective anatomic success rates for patients un-
dergoing LSC with or without a cystocele as the dominant prolapse
before operation were 50% (4/8) and 93.5% (29/31), respectively. By
contrast, the objective anatomic success rates for patients under-
going a TVM procedure with or without suspension of prolapsed
(POPQ Stage  2) uterus during operation were 78.6% (11/14) and
93.8% (15/16), respectively.
Discussion
To the best of our knowledge, this is the ﬁrst study to compare
surgical outcomes between LSC and TVM using the new light-
weight meshes. Both anatomic and functional outcomes seemed
favorable and were comparable after the two procedures. However,
the dominant anatomic recurrence after LSC was cystocele,
whereas after TVM it was uterine or vaginal vault prolapse. After a
statistical analysis, we found that “cystocele as the dominant pro-
lapse before operation” and “suspension of prolapsed (POPQ
Stage  2) uterus” during operation were signiﬁcant predisposing
factors for recurrence after LSC and TVM, respectively.
Different demographic data between groups was the result of
non-randomization. The major differences were age and age-
related factors, i.e., parity, body mass index, and menopause. The
results suggested that, after clinical counseling, older patients
tended to accept a TVM procedure because of the less-invasive
vaginal approach and younger patients tended to undergo an
LSC because of the impression that the procedure was associated
with a long-lasting effect and less likely to have a negative inﬂu-
ence on sexual function [2]. In addition, both groups in this study
mainly included POP cases without a previous history of prolapse
repair or hysterectomy. Therefore, our results demonstrate the
effectiveness of the two procedures as primary surgeries for
treatment of POP.
The two procedures had favorable perioperative outcomes with
the longer operating time being a disadvantage of LSC, which was
offset by a signiﬁcant reduction in blood loss, length of hospital
stay, and catheterization time compared with the TVM group. The
signiﬁcant difference in the length of operation might be attribut-
able to the index procedures, because the rates of concomitant
surgeries were comparable between groups. Our results indicated
that LSC was associated with a shorter convalescence despite a
longer operating time when compared to TVM. This ﬁnding was
consistent with that of an RCT conducted by Maher et al [14];
however, they used original meshes.At 1 year, our anatomic data and subsequent statistical analyses
showed similar objective anatomic success rates after the two
procedures. LSC was signiﬁcantly superior to TVM for apical sus-
pension but was relatively inferior to TVM for anterior repair. The
advantages of sacrocolpopexy procedures over several vaginal
procedures for apical suspension are well known [2]. By contrast,
the weakness of LSC for anterior repair has been noted but has not
been investigated in recent studies using the Y-shaped mesh
[8,23,24]. In the present study, all six (15.4%) recurrences after LSC
were cystoceles. A statistical analysis was conducted which showed
that a dominant cystocele before operation may contribute to
recurrence at the same site. Because the anterior compartment was
repaired by merely anchoring the anterior leaf of a Y-shaped mesh
along the vaginal length, the recurrence most likely was a result of
the lateral defects of a cystocele that was not repaired by this
technique [25]. Some surgeons perform additional retropubic par-
avaginal repair or colposuspension with sacrocolpopexy pro-
cedures in patients with severe cystocele [13,14,16,26,27]. Although
this may decrease the chance of recurrence at the anterior site, it
may not improve the overall success rate for a POP repair because of
the predisposition to a recurrence in the posterior compartment
[13,16,26]. Fortunately, our results suggested that most of the
recurrent cystoceles after LSC using the Y-shaped mesh were not
problematic because of the intravaginal position and absence of
symptoms.
By contrast, our results suggested that TVM was signiﬁcantly
inferior to LSC for apical suspensionwith more recurrent uterine or
vaginal vault prolapses. Similar results were noted in previous
studies that indicated TVM was associated with suboptimal results
for apical suspension judged by POPQ parameters (i.e., a lower C
point and a shorter TVL) but may not have a lower overall success
rate [14,28,29]. In the present study, a statistical analysis was per-
formed and we found that the suspension of a prolapsed (POPQ
Stage  2) uterus with TVM using the new lightweight meshes
signiﬁcantly affected the rate of recurrence. This ﬁnding was
different from those of previous studies of TVM using original
meshes, in that uterine preservation can reduce the rate of vaginal
mesh extrusion but does not seem to be associated with a
compromised anatomic success rate [30,31]. The difference may be
due to the new lightweight meshes used and the fact that the ef-
fects of a uterine suspension (POPQ Stage  2) or conservation
(POPQ Stage  1) on the TVM procedure were evaluated separately
in this study. Our results suggested that the new lightweight
meshes may have aweaker suspension force than the original ones,
which cannot withstand the excessive load of a prolapsed uterus
indeﬁnitely and eventually cause recurrent uterine prolapse.
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cedures at 1-year follow-up. Various pelvic symptoms and their
negative impacts on quality of life were signiﬁcantly reduced.
Sexual function scores improved, but were not statistically signiﬁ-
cant after the two procedures. An interesting ﬁnding was that there
was a low percentage of sexual activity in both groups prior to the
operation; however, the rates increased signiﬁcantly after the
operation and were not signiﬁcantly different between groups. This
may be attributable to patient satisfaction and our encouraging
patients to engage in sexual intercourse after a smooth recovery. In
addition, the stable rates of dyspareunia before and after the sur-
gery suggested the two procedures did not cause additional nega-
tive impacts on sexual intercourse. Meanwhile, the rates were
within the normal ranges after a native tissue vaginal repair [2].
No serious complications were noted in this study. De novo
stress incontinence was the most prevalent complication after both
procedures. The occurrence of this condition was reported to be
multifactorial with rates ranging between 25% and 54.5% [32e35].
Our rates were low, which may be attributable to our strategy of
managing stress incontinence concomitantly in POP repair. An
additional midurethral sling was performed for both overt and
occult stress incontinence after a thorough urodynamic study and
history review. An updated Cochrane review also indicated a
reduced rate following the strategy [2]. In addition, an extremely
low rate of vaginal mesh extrusion was noted in the present study.
Because we followed the standard surgical techniques, the low rate
may be due to the new lightweight meshes, which have been re-
ported to be associated with signiﬁcantly fewer mesh extrusions
compared to the original ones [9,11,12]. In contrast to the RCT
conducted by Maher et al [14], where mesh-related complications
were the major indication for reoperation, the indication in the
present studywas recurrent POP. This ﬁnding further supported the
improved safety proﬁle for using lightweight meshes in POP repair.
The limitations of this study were nonrandomization and a
relatively small number of cases. However, the strengths included a
homogeneous patient population and the application of multivar-
iate logistic regression analyses to avoid potential confounding
factors. In addition, the assessor whowas responsible for follow-up
assessment and data collectionwas blinded to patient baseline data
to eliminate possible bias in this study.
In conclusion, our study results suggested the new lightweight
polypropylene meshes were safe for use in LSC and TVM and
resulted in favorable and comparable anatomic and functional
outcomes. However, the limitation in treating selective vaginal
defects with each procedure, noted in this study, indicates the
importance of individualized treatment. The information obtained
may be beneﬁcial in clinical counseling for mesh-augmented POP
repair. Further prospective RCTs are needed to better evaluate the
cost-effectiveness and long-term efﬁcacy of LSC and TVM using the
new lightweight meshes.Conﬂicts of interest
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